Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06400979 · ClinicalTrials.gov registry record · NA
Aromatherapy for Management of Pain, Anxiety, and Nausea in the Acute Care Setting
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT06400979 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 94 participants.
The verdict
NCT06400979, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this interventional study is to investigate the effects of aromatherapy on an acute care unit and whether it is effective in decreasing physical or emotional stressors that occur as a hospitalized patient. This study aimed to expand the limited literature on aromatherapy use in hospitalized adults and its effectiveness in decreasing pain, anxiety, and nausea. The hypothesis was that use of aromatherapy would decrease pain, anxiety and nausea in hospitalized adults and increase patient satisfaction. While there is anecdotal evidence of its efficacy, few studies exist evaluating its effectiveness within peer-reviewed journals, specifically on acute care medical surgical units.
Interventions
- DEVICE Elequil aromatab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2022-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06400979
The ClinicalTrials.gov registry entry for NCT06400979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Elequil aromatab is the first listed.
NCT06400979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06400979 about?
NCT06400979 is a clinical study titled "Aromatherapy for Management of Pain, Anxiety, and Nausea in the Acute Care Setting". The purpose of this interventional study is to investigate the effects of aromatherapy on an acute care unit and whether it is effective in decreasing physical or emotional stressors that occur as a hospitalized patient. This study aimed to expand the limited literature on aromatherapy use in hospit...
What is the current status of trial NCT06400979?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2020-12-01. Estimated completion is 2022-05-01.
What interventions are being tested in trial NCT06400979?
The interventions under investigation include: Elequil aromatab (DEVICE).
Who is sponsoring clinical trial NCT06400979?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.